6-pyrimidinyl-pyrimid-4-one derivative
AssigneesSanofi-Aventis, Mitsubishi Tanabe Pharma Corporation
InventorsKenji FUKUNAGA, Kazutoshi WATANABE, Pascal BARNEOUD, Jesus BENAVIDES, Jeremy PRATT
Life of this patent
Estimating the term…
Abstract
A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).
Claims4
A method of treating a neurodegenerative disease comprising administering a compound represented by formula (I)
- or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.
A method of treating non-insulin dependent diabetes comprising administering a compound represented by formula (I)
- or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.
A method of treating a disease characterized by cognitive and memory deficits comprising administering a compound represented by formula (I)
- or a pharmaceutically acceptable salt thereof to a patient in need of such treatment.
Dependencies are inferred from the claim text.